Individuals with cystic fibrosis or CFTR gene variants have a 3-fold higher risk of developing pancreatic cancer after 50 years of age.

BiomX has published promising phase 1b/2a trial results in Nature Communications, demonstrating that its phage cocktail BX004 ...

Cystic fibrosis is a hereditary disease caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The CFTR gene encodes an ion channel protein that is involved in ...

The report of one of these bodies, the ACMG Subcommittee on Cystic Fibrosis Screening, appears in this issue of Genetics in Medicine. 21 It represents the end result of many hours of deliberation ...

Vertex Pharmaceuticals’ cystic fibrosis (CF) therapy Alyftrek (deutivacaftor/tezacaftor/vanzacaftor) has been approved by the European Commission (EC).

Premier research journal article provides validation for BiomX’s phage therapy platform, showcasing first-in-human Phase ...

The gene-editing platform known as Crispr is widely used by researchers in scientific laboratories in their search for new ...

Libya's healthcare crisis has a sad, new face. It is that of a tired 7-year-old girl, Sohan Aboulsoud, who suffers from ...

A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...

In a paper published last month, researchers at UT Southwestern Medical Center introduced lipid nanoparticles — hollow, fatty ...

The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense ...